Cyclopentolate and phenylephrine ophthalmic and Insulin lispro Subcutaneous
Determining the interaction of Cyclopentolate and phenylephrine ophthalmic and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclopentolate / phenylephrine ophthalmic
Brand name: Cyclomydril
Synonyms: Cyclopentolate and Phenylephrine
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyclopentolate and phenylephrine ophthalmic-Insulin NPH
- Cyclopentolate and phenylephrine ophthalmic-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Cyclopentolate and phenylephrine ophthalmic-Insulin NPH (Vials)
- Cyclopentolate and phenylephrine ophthalmic-Insulin NPH and Insulin Regular
- Cyclopentolate and phenylephrine ophthalmic-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Cyclopentolate and phenylephrine ophthalmic-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Cyclopentolate Hydrochloride
- Insulin lispro Subcutaneous-Cyclopentolate ophthalmic
- Insulin lispro Subcutaneous-Cyclophosphamide
- Insulin lispro Subcutaneous-Cyclophosphamide Capsules
- Insulin lispro Subcutaneous-Cyclophosphamide Injection
- Insulin lispro Subcutaneous-Cyclophosphamide oral and injection